{"id":952542,"date":"2026-04-17T10:43:36","date_gmt":"2026-04-17T14:43:36","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/ibrx-shareholder-alert-immunitybio-inc-securities-class-action-lawsuit-investors-with-losses-may-join-the-gross-law-firm\/"},"modified":"2026-04-17T10:43:36","modified_gmt":"2026-04-17T14:43:36","slug":"ibrx-shareholder-alert-immunitybio-inc-securities-class-action-lawsuit-investors-with-losses-may-join-the-gross-law-firm","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/ibrx-shareholder-alert-immunitybio-inc-securities-class-action-lawsuit-investors-with-losses-may-join-the-gross-law-firm\/","title":{"rendered":"IBRX Shareholder Alert: ImmunityBio, Inc. Securities Class Action Lawsuit Investors With Losses May Join \u2014 The Gross Law Firm"},"content":{"rendered":"<div class=\"mw_release\">\n<p>NEW YORK, April  17, 2026  (GLOBE NEWSWIRE) &#8212; The Gross Law Firm issues the following notice to shareholders of <strong>ImmunityBio, Inc. (NASDAQ: IBRX).<\/strong><\/p>\n<p>Shareholders who purchased shares of IBRX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.<\/p>\n<p align=\"center\">CONTACT US HERE:<\/p>\n<p align=\"center\">\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=4kQifppJVMkHAxkcYN4huytLnhrGhlxspQ96juXHFLkLH27lenexU85D50Kw4c-CsnH5_nBFgaCC8vcilJSn2iwOr644mrjX1E2WCMQOYi0cv1LafKodb0QM2-4Mx9HREE8Yp_xhza-VXRtMhfFHf0T0Jz24coIEBsTvxMlBdF5k0t-lezgE73Xbp6Sky3ZqX_7k2KtzUz0AeZn4m1W8r8izicwbwV85hETF02w8oQb5sdbR0ZIFOw1M7RPF5mpBd5RkoToul7IdEdCKWBQYSV2r9100Y5XaNXLdNcAoT-4=\" rel=\"nofollow\" target=\"_blank\">https:\/\/securitiesclasslaw.com\/securities\/immunitybio-inc-loss-submission-form\/?id=185583&amp;from=3<\/a>\u00a0<\/p>\n<p>\n        <strong>CLASS PERIOD: <\/strong>January 19, 2026 to March 24, 2026<\/p>\n<p>\n        <strong>ALLEGATIONS: <\/strong>The complaint alleges that during the class period, Defendants issued materially false and\/or misleading statements and\/or failed to disclose that: (1) defendant Soon-Shion materially overstated Anktiva\u2019s capabilities; and (2) as a result, defendants\u2019 statements about ImmunityBio\u2019s business, operations, and prospects were materially false and misleading and\/or lacked a reasonable basis at all relevant times.<\/p>\n<p>\n        <strong>DEADLINE: May 26, 2026<\/strong> Shareholders should not delay in registering for this class action. Register your information here: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=4kQifppJVMkHAxkcYN4huytLnhrGhlxspQ96juXHFLkLH27lenexU85D50Kw4c-CsnH5_nBFgaCC8vcilJSn2iwOr644mrjX1E2WCMQOYi0cv1LafKodb0QM2-4Mx9HREE8Yp_xhza-VXRtMhfFHfx1UF9bDdMunjXLE44pByRz8fW7_jDC6_IE248cGEsuk7wrHgbvLHeu1fodaDrM79r_FQRS2wDZXx82087HTWEzw6U9lS6pPibVqm_qmO3YTGwqfCqmQdWyG_qaMqufDbCsp8IGsGwPU9--dHQtmQwk=\" rel=\"nofollow\" target=\"_blank\">https:\/\/securitiesclasslaw.com\/securities\/immunitybio-inc-loss-submission-form\/?id=185583&amp;from=3<\/a>\u00a0<\/p>\n<p>\n        <strong>NEXT STEPS FOR SHAREHOLDERS: <\/strong>Once you register as a shareholder who purchased shares of IBRX during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is May 26, 2026. There is no cost or obligation to you to participate in this case.<\/p>\n<p>\n        <strong>WHY GROSS LAW FIRM? <\/strong>The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and\/or misleading statements or the omission of material information by a company lead to artificial inflation of the company&#8217;s stock. Attorney advertising. Prior results do not guarantee similar outcomes.<\/p>\n<p>\n        <strong>CONTACT:<\/strong><br \/>\n        <br \/>The Gross Law Firm<br \/>15 West 38th Street, 12th floor<br \/>New York, NY, 10018<br \/>Email: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=RcjLCvQUxU4zYgDfEecidQgcLRev2FS6TJ6gd4w-xMEf29Nu3eUe7Qfp5M3AsbUulwdjm0i65TW4NUkqt_rzequ_MwRwspRJe-zzRe4AEumFs5-JYYlYiuzxYlfAvMaT\" rel=\"nofollow\" target=\"_blank\">dg@securitiesclasslaw.com<\/a>\u00a0<br \/>Phone: (646) 453-8903<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY5MTUyNyM3NTQwMjQwIzIyNTg5MTc=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/OTdhOTJiZTItYjY4NS00ZDkyLTllMWEtODc0NDEzZDM1ZTdlLTEyNzA0NjctMjAyNi0wNC0xNy1lbg==\/tiny\/The-Gross-Law-Firm.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEW YORK, April 17, 2026 (GLOBE NEWSWIRE) &#8212; The Gross Law Firm issues the following notice to shareholders of ImmunityBio, Inc. (NASDAQ: IBRX). Shareholders who purchased shares of IBRX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https:\/\/securitiesclasslaw.com\/securities\/immunitybio-inc-loss-submission-form\/?id=185583&amp;from=3\u00a0 CLASS PERIOD: January 19, 2026 to March 24, 2026 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and\/or misleading statements and\/or failed to disclose that: (1) defendant Soon-Shion materially overstated Anktiva\u2019s capabilities; and (2) as a result, defendants\u2019 statements about ImmunityBio\u2019s business, operations, and prospects were materially false and misleading and\/or lacked a reasonable &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/ibrx-shareholder-alert-immunitybio-inc-securities-class-action-lawsuit-investors-with-losses-may-join-the-gross-law-firm\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;IBRX Shareholder Alert: ImmunityBio, Inc. Securities Class Action Lawsuit Investors With Losses May Join \u2014 The Gross Law Firm&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-952542","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>IBRX Shareholder Alert: ImmunityBio, Inc. Securities Class Action Lawsuit Investors With Losses May Join \u2014 The Gross Law Firm - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/ibrx-shareholder-alert-immunitybio-inc-securities-class-action-lawsuit-investors-with-losses-may-join-the-gross-law-firm\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"IBRX Shareholder Alert: ImmunityBio, Inc. Securities Class Action Lawsuit Investors With Losses May Join \u2014 The Gross Law Firm - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK, April 17, 2026 (GLOBE NEWSWIRE) &#8212; The Gross Law Firm issues the following notice to shareholders of ImmunityBio, Inc. (NASDAQ: IBRX). Shareholders who purchased shares of IBRX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https:\/\/securitiesclasslaw.com\/securities\/immunitybio-inc-loss-submission-form\/?id=185583&amp;from=3\u00a0 CLASS PERIOD: January 19, 2026 to March 24, 2026 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and\/or misleading statements and\/or failed to disclose that: (1) defendant Soon-Shion materially overstated Anktiva\u2019s capabilities; and (2) as a result, defendants\u2019 statements about ImmunityBio\u2019s business, operations, and prospects were materially false and misleading and\/or lacked a reasonable &hellip; Continue reading &quot;IBRX Shareholder Alert: ImmunityBio, Inc. Securities Class Action Lawsuit Investors With Losses May Join \u2014 The Gross Law Firm&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/ibrx-shareholder-alert-immunitybio-inc-securities-class-action-lawsuit-investors-with-losses-may-join-the-gross-law-firm\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-17T14:43:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY5MTUyNyM3NTQwMjQwIzIyNTg5MTc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ibrx-shareholder-alert-immunitybio-inc-securities-class-action-lawsuit-investors-with-losses-may-join-the-gross-law-firm\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ibrx-shareholder-alert-immunitybio-inc-securities-class-action-lawsuit-investors-with-losses-may-join-the-gross-law-firm\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"IBRX Shareholder Alert: ImmunityBio, Inc. Securities Class Action Lawsuit Investors With Losses May Join \u2014 The Gross Law Firm\",\"datePublished\":\"2026-04-17T14:43:36+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ibrx-shareholder-alert-immunitybio-inc-securities-class-action-lawsuit-investors-with-losses-may-join-the-gross-law-firm\\\/\"},\"wordCount\":358,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ibrx-shareholder-alert-immunitybio-inc-securities-class-action-lawsuit-investors-with-losses-may-join-the-gross-law-firm\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY5MTUyNyM3NTQwMjQwIzIyNTg5MTc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ibrx-shareholder-alert-immunitybio-inc-securities-class-action-lawsuit-investors-with-losses-may-join-the-gross-law-firm\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ibrx-shareholder-alert-immunitybio-inc-securities-class-action-lawsuit-investors-with-losses-may-join-the-gross-law-firm\\\/\",\"name\":\"IBRX Shareholder Alert: ImmunityBio, Inc. Securities Class Action Lawsuit Investors With Losses May Join \u2014 The Gross Law Firm - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ibrx-shareholder-alert-immunitybio-inc-securities-class-action-lawsuit-investors-with-losses-may-join-the-gross-law-firm\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ibrx-shareholder-alert-immunitybio-inc-securities-class-action-lawsuit-investors-with-losses-may-join-the-gross-law-firm\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY5MTUyNyM3NTQwMjQwIzIyNTg5MTc=\",\"datePublished\":\"2026-04-17T14:43:36+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ibrx-shareholder-alert-immunitybio-inc-securities-class-action-lawsuit-investors-with-losses-may-join-the-gross-law-firm\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ibrx-shareholder-alert-immunitybio-inc-securities-class-action-lawsuit-investors-with-losses-may-join-the-gross-law-firm\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ibrx-shareholder-alert-immunitybio-inc-securities-class-action-lawsuit-investors-with-losses-may-join-the-gross-law-firm\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY5MTUyNyM3NTQwMjQwIzIyNTg5MTc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY5MTUyNyM3NTQwMjQwIzIyNTg5MTc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ibrx-shareholder-alert-immunitybio-inc-securities-class-action-lawsuit-investors-with-losses-may-join-the-gross-law-firm\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"IBRX Shareholder Alert: ImmunityBio, Inc. Securities Class Action Lawsuit Investors With Losses May Join \u2014 The Gross Law Firm\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"IBRX Shareholder Alert: ImmunityBio, Inc. Securities Class Action Lawsuit Investors With Losses May Join \u2014 The Gross Law Firm - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/ibrx-shareholder-alert-immunitybio-inc-securities-class-action-lawsuit-investors-with-losses-may-join-the-gross-law-firm\/","og_locale":"en_US","og_type":"article","og_title":"IBRX Shareholder Alert: ImmunityBio, Inc. Securities Class Action Lawsuit Investors With Losses May Join \u2014 The Gross Law Firm - Market Newsdesk","og_description":"NEW YORK, April 17, 2026 (GLOBE NEWSWIRE) &#8212; The Gross Law Firm issues the following notice to shareholders of ImmunityBio, Inc. (NASDAQ: IBRX). Shareholders who purchased shares of IBRX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https:\/\/securitiesclasslaw.com\/securities\/immunitybio-inc-loss-submission-form\/?id=185583&amp;from=3\u00a0 CLASS PERIOD: January 19, 2026 to March 24, 2026 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and\/or misleading statements and\/or failed to disclose that: (1) defendant Soon-Shion materially overstated Anktiva\u2019s capabilities; and (2) as a result, defendants\u2019 statements about ImmunityBio\u2019s business, operations, and prospects were materially false and misleading and\/or lacked a reasonable &hellip; Continue reading \"IBRX Shareholder Alert: ImmunityBio, Inc. Securities Class Action Lawsuit Investors With Losses May Join \u2014 The Gross Law Firm\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/ibrx-shareholder-alert-immunitybio-inc-securities-class-action-lawsuit-investors-with-losses-may-join-the-gross-law-firm\/","og_site_name":"Market Newsdesk","article_published_time":"2026-04-17T14:43:36+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY5MTUyNyM3NTQwMjQwIzIyNTg5MTc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ibrx-shareholder-alert-immunitybio-inc-securities-class-action-lawsuit-investors-with-losses-may-join-the-gross-law-firm\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ibrx-shareholder-alert-immunitybio-inc-securities-class-action-lawsuit-investors-with-losses-may-join-the-gross-law-firm\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"IBRX Shareholder Alert: ImmunityBio, Inc. Securities Class Action Lawsuit Investors With Losses May Join \u2014 The Gross Law Firm","datePublished":"2026-04-17T14:43:36+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ibrx-shareholder-alert-immunitybio-inc-securities-class-action-lawsuit-investors-with-losses-may-join-the-gross-law-firm\/"},"wordCount":358,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ibrx-shareholder-alert-immunitybio-inc-securities-class-action-lawsuit-investors-with-losses-may-join-the-gross-law-firm\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY5MTUyNyM3NTQwMjQwIzIyNTg5MTc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ibrx-shareholder-alert-immunitybio-inc-securities-class-action-lawsuit-investors-with-losses-may-join-the-gross-law-firm\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/ibrx-shareholder-alert-immunitybio-inc-securities-class-action-lawsuit-investors-with-losses-may-join-the-gross-law-firm\/","name":"IBRX Shareholder Alert: ImmunityBio, Inc. Securities Class Action Lawsuit Investors With Losses May Join \u2014 The Gross Law Firm - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ibrx-shareholder-alert-immunitybio-inc-securities-class-action-lawsuit-investors-with-losses-may-join-the-gross-law-firm\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ibrx-shareholder-alert-immunitybio-inc-securities-class-action-lawsuit-investors-with-losses-may-join-the-gross-law-firm\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY5MTUyNyM3NTQwMjQwIzIyNTg5MTc=","datePublished":"2026-04-17T14:43:36+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ibrx-shareholder-alert-immunitybio-inc-securities-class-action-lawsuit-investors-with-losses-may-join-the-gross-law-firm\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/ibrx-shareholder-alert-immunitybio-inc-securities-class-action-lawsuit-investors-with-losses-may-join-the-gross-law-firm\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ibrx-shareholder-alert-immunitybio-inc-securities-class-action-lawsuit-investors-with-losses-may-join-the-gross-law-firm\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY5MTUyNyM3NTQwMjQwIzIyNTg5MTc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY5MTUyNyM3NTQwMjQwIzIyNTg5MTc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ibrx-shareholder-alert-immunitybio-inc-securities-class-action-lawsuit-investors-with-losses-may-join-the-gross-law-firm\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"IBRX Shareholder Alert: ImmunityBio, Inc. Securities Class Action Lawsuit Investors With Losses May Join \u2014 The Gross Law Firm"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/952542","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=952542"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/952542\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=952542"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=952542"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=952542"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}